ZofranLegal.com reports on another lawsuit filed against anti-nausea drug Zofran, and manufacturer GlaxoSmithKline. This suit comes from a couple who live in Brazoria, Texas, and filed complaint no. 1:15-CV-00637-UNA in the United States District Court for the District of Delaware on July 24th, 2015.
The complaint alleges that each of the couple’s two children were born with congenital defects due to exposure to Zofran while developing in utero. The lawsuit is one of over 60 which now allegedly link the drug to various birth defects.
According to this specific suit, the couple’s children were born with two different defects. One suffered from heart defects, while the other suffered kidney defects. Their first child was born with congenital heart defects which proved fatal when the child passed away at less than 1 month of age. The second child, which was similarly exposed to Zofran during the first trimester, was born with kidney defects that were described as “permanent and lasting..” just three years after the first child had died.
The mother notes that while pregnant with the first child in 2000, an early ultrasound indicated that the baby was developing properly and had no signs of abnormalities. This was before she began using Zofran to combat her nausea and vomiting. Soon after this, she began using the drug for the remainder of her first trimester, when risk for the development of birth defects are the highest.
After birth, their first child was immediately transferred to the NICU area of another Texas hospital and was placed on a ventilator due to breathing difficulties. The daughter remained here for the remainder of her brief life, according to documentation from the parents. She passed away from multiple severe heart malformations, including “a heart whose left side was one-fifth of its normal size and an aorta that was severely malformed.” This statement likely refers to the condition hypoplastic left heart syndrome.
Just two years later, the couple became pregnant with their second child, and the mother was again prescribed Zofran to relieve nausea symptoms. What she notes now that she did not know then, was that the drug had never been approved for use by pregnant women, or tested for safety concerning developing fetuses.
Again, the mother delivered what was termed a “high-risk” baby, who was kept in the hospital for an extended period of time and who, parents note, underwent “extensive testing.” Today, parents say, the child continues to suffer from reflux and urinary and kidney maladies.
As similar lawsuits appear across the U.S., the attorneys at Monheit Law are working to ensure that everyone involved is able to evaluate their legal rights. Women who have used Zofran while pregnant and have given birth to a child with defects may be entitled to compensation. Lawyers at Monheit Law are currently providing free consultations to help these individuals.
For additional information concerning Zofran or Zofran Birth Defects, or to ask questions, please contact Michael Monheit, Esq. at 877-620-8411.
###
Contact ZofranLegal.com:
Michael Monheit
1-877-620-8411
michael@monheit.com
1368 Barrowdale Road, Rydal, PA 19046
